Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

por Klimek, Ludger, Bachert, Claus, Lukat, Karl-Friedrich, Pfaar, Oliver, Meyer, Hanns, Narkus, Annemie
Publicado 2015

ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential

por Ruck, Tobias, Afzali, Ali Maisam, Lukat, Karl-Friedrich, Eveslage, Maria, Gross, Catharina C., Pfeuffer, Steffen, Bittner, Stefan, Klotz, Luisa, Melzer, Nico, Wiendl, Heinz, Meuth, Sven G.
Publicado 2016